Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide

Transplantation

Volumn 71, Issue 1, 2001, Pages 170-174

  Knight, Deborah A ^a   Hejmanowski, Ashley Quintin ^a   Dierksheide, Julie E ^a   Williams, James W ^b   Chong, Anita S F ^b   Waldman, W James ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; LEFLUNOMIDE; TERIFLUNOMIDE;

ALLOGRAFT; ANTIVIRAL ACTIVITY; ARTICLE; BONE MARROW TRANSPLANTATION; ENZYME ACTIVITY; GRAFT VERSUS HOST REACTION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECIPIENT; TRANSMISSION ELECTRON MICROSCOPY; VIRUS CULTURE; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS REACTIVATION;

EID: 0035862995     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200101150-00031     Document Type: Article

References (17)

1. Infection with herpes simplex virus and cell-mediated immunity after marrow transplant
2. Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation
3. Antiviral therapy of herpes simplex and varicellazoster virus infections
4. Foscarnet: A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections
5. An evaluation of leflunomide in the canine renal transplantation model
6. In vivo activity of leflunomide: Pharmacokinetic analyses and mechanism of immunosuppression
7. Pharmacologically induced regression of chronic transplant rejection
8. Lefiunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection
9. The immunosuppressive metabolite of leflunomide, A77 1726, affects murine T cells through two biochemical mechanisms
10. Novel mechanism of inhibition of cytomegalovirns by the experimental immunosuppressive agent Leflunomide
11. Herpes simplex viruses and their replication
12. Herpesviridae in the coronary arteries and aorta of young trauma victims
13. Infection of the corneal endothelium in herpes simplex keratitis
14. In vivo activity of leflunomide: Pharmacokinetic analyses and mechanism of immunosuppression
15. Isolation of a herpes simplex virus type 1 mutant deleted for the essential UL42 gene and characterization of its null phenotype
16. Posttranslational modification of the tegument proteins (VP13 and VP14) of herpes simplex type 1 by glycosylation and phosphorylation
17. Identification of phosphorylation sites within herpes simplex virus tegument protein VP22